PRESS RELEASE published on 04/28/2026 at 22:00, 9 days 2 hours ago FORVIA: IMPLEMENTATION OF THE SHARE BUYBACK PROGRAM APPROVED BY THE SHAREHOLDERS’ MEETING HELD ON 28 MAY 2025 FORVIA implements share buyback program approved by shareholders' meeting for acquisition of up to 1,100,000 shares, aiming to benefit employees and officers. Details on program and resolution available on company's website Acquisition Share Buyback Performance Share Plans Investment Services Forvia
PRESS RELEASE published on 04/28/2026 at 22:00, 9 days 2 hours ago FORVIA : MISE EN OEUVRE DU PROGRAMME DE RACHAT D'ACTIONS APPROUVÉ PAR L'ASSEMBLÉE GÉNÉRALE DU 28 MAI 2025 FORVIA lance programme rachat actions approuvé Assemblée Générale 28/05/2025, 1.1M actions maximum. Couverture obligations plans performance salariés. Détails sur site www.forvia.com Assemblée Générale Performance Salariés Rachat Actions Forvia
PRESS RELEASE published on 04/28/2026 at 21:55, 9 days 2 hours ago Piramal Pharma Limited Announces Results for Q4 and Full-year FY26 Piramal Pharma Limited announces Q4 and full-year FY26 results, highlighting growth in revenue, EBITDA margin, and key business developments amidst external disruptions. Read more here Financial Report Q4 Results Business Highlights FY26 Piramal Pharma Limited
PRESS RELEASE published on 04/28/2026 at 21:00, 9 days 3 hours ago VAT Group AG Annual General Meeting 2026: Shareholders approved all Board proposals and a dividend increase of 12% to CHF 7.00 per share VAT Group AG shareholders approve 12% dividend increase to CHF 7.00 per share at 2026 Annual General Meeting Shareholders Dividend Increase AGM VAT Group AG CHF 7.00
PRESS RELEASE published on 04/28/2026 at 20:35, 9 days 4 hours ago Informations privilégiées / Autres communiqués GenSight Biologics annonce sa prochaine Assemblée Générale Mixte du 19 mai 2026 avec mise à disposition des documents préparatoires. Informations complètes disponibles sur le site de la Société Documents Préparatoires Assemblée Générale Mixte GenSight Biologics Thérapies Géniques Maladies Neurodégénératives
PRESS RELEASE published on 04/28/2026 at 20:35, 9 days 4 hours ago Inside Information / Other news releases GenSight Biologics to hold Annual General Meeting on May 19, 2026, in Paris. Shareholders can access preparatory documents online. Meeting details and documents available on company website Annual General Meeting Shareholders Preparatory Documents Meeting Details GenSight Biologics
PRESS RELEASE published on 04/28/2026 at 20:30, 9 days 4 hours ago Artmarket by Artprice: Résultats de l'activité 2025 et mise à disposition du rapport financier annuel 2025 avec un CA record
PRESS RELEASE published on 04/28/2026 at 20:00, 9 days 4 hours ago Point sur la publication du Rapport financier annuel 2025 La Société CALIBRE rencontre un retard dans la production de ses comptes 2025 en raison d'opérations comptables complexes avec EVIKE et VERNEY-CARRON. Des efforts sont faits pour la publication. Découvrez plus sur www.calibre-groupe.com Rapport Financier EVIKE VERNEY-CARRON CALIBRE Retard Production Comptes
PRESS RELEASE published on 04/28/2026 at 20:00, 9 days 4 hours ago Mise à disposition du rapport financier annuel 2025 BOGART publie son rapport financier annuel 2025 avec AMF incluant rapports de gestion et comptes annuels. Disponible sur le site https://www.groupe-bogart.com/investisseurs/rapports-financiers.html AMF Rapport Financier Investisseurs Comptes Annuels BOGART
PRESS RELEASE published on 04/28/2026 at 19:53, 9 days 4 hours ago EQS-Adhoc: Scout24 SE resolves to launch a second tranche of its share buy-back programme of up to EUR 250 million in 2026 and to shorten the buy-back period of the ongoing tranche Scout24 SE launches second tranche of share buy-back program of up to EUR 250 million in 2026, shortening the ongoing tranche period. Management Board and Supervisory Board approved the decision Share Buy-back Program Management Board Scout24 SE 2026 EUR 250 Million
Published on 05/08/2026 at 00:00, 35 minutes ago Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 1 hour 5 minutes ago Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 1 hour 20 minutes ago BULGOLD Adopts Semi-Annual Financial Reporting
Published on 05/07/2026 at 22:05, 2 hours 30 minutes ago MicroVision and Avular Collaborate to Advance Autonomous Sensing and Drone Integration for Next-Generation Infrastructure Applications
Published on 05/07/2026 at 22:05, 2 hours 30 minutes ago Innodata Reports Record First Quarter 2026 Results
Published on 05/07/2026 at 23:23, 1 hour 11 minutes ago H1 25/26: Challenging environment and significant changes in IT market // Revised forecast // Programme to boost competitiveness
Published on 05/07/2026 at 23:14, 1 hour 20 minutes ago EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 2 hours 29 minutes ago Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 3 hours 52 minutes ago RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 5 hours 49 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/07/2026 at 19:15, 5 hours 20 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 5 hours 20 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 5 hours 29 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 5 hours 29 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 5 hours 35 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL